OSI Pharmaceuticals Inc. (Osip)

[surf1944]

4:13PM OSI Pharm reports Q1 (Mar) results, misses on revs (OSIP) 58.66 -0.79 : Reports Q1 (Mar) earnings of $0.63 per share, excludes items and may not be comparable to the Thomson Reuters consensus of $0.33; revenues rose 13.4% year/year to $106.6 mln vs the $115 mln consensus. OSI Pharm reports Q1 Tarceva sales of $308 mln vs. $325 Thomson Reuters Consensus. Royalties on product licenses of $40 million for the first quarter of 2010 compared to $34 million in the first quarter of 2009 from Roche - for sales of Tarceva.